Max Donley

2021 - Aurinia Pharmaceuticals

In 2021, Max Donley earned a total compensation of $730.2K as EVP, Operations and Strategy at Aurinia Pharmaceuticals, a 78% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$269,392
Salary$448,986
Other$11,828
Total$730,206

Donley received $449K in salary, accounting for 61% of the total pay in 2021.

Donley also received $269.4K in non-equity incentive plan and $11.8K in other compensation.

Rankings

In 2021, Max Donley's compensation ranked 9,765th out of 12,415 executives tracked by ExecPay. In other words, Donley earned more than 21.3% of executives.

ClassificationRankingPercentile
All
9,765
out of 12,415
21st
Division
Manufacturing
4,327
out of 5,505
21st
Major group
Chemicals And Allied Products
1,922
out of 2,375
19th
Industry group
Drugs
1,706
out of 2,096
19th
Industry
Pharmaceutical Preparations
1,268
out of 1,546
18th

Pay ratio

Max Donley's Pay$730,206
Median Employee's Pay$255,489
Pay Ratio

3

to 1

In 2021, the annual total compensation of Max Donley was $730,206.

The annual total compensation of the median employee at Aurinia Pharmaceuticals was $255,489.

The ratio of Max Donley's pay to the pay of median employee was therefore 3 to one.

Source: SEC filing on April 18, 2022.

Donley's colleagues

We found four more compensation records of executives who worked with Max Donley at Aurinia Pharmaceuticals in 2021.

2021

Peter Greenleaf

Aurinia Pharmaceuticals

Chief Executive Officer

2021

Stephen Robertson

Aurinia Pharmaceuticals

General Counsel

2021

Joe Miller

Aurinia Pharmaceuticals

Chief Financial Officer

2021

Max Colao

Aurinia Pharmaceuticals

Chief Commercial Officer

News

You may also like